MND.TO(MND.TO)
MND.TO
No analyst ratings available
No analyst price targets available for MND.TO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $305M | $247M | $219M | $219M |
| Low | $305M | $247M | $219M | $219M |
| High | $305M | $247M | $219M | $219M |
| EBITDA Avg | $122M | $99M | $87M | $87M |
| Low | $122M | $99M | $87M | $87M |
| High | $122M | $99M | $87M | $87M |
| EBIT Avg | $68M | $55M | $49M | $49M |
| Low | $68M | $55M | $49M | $49M |
| High | $68M | $55M | $49M | $49M |
| Net Income Avg | $112M | $57M | $44M | $47M |
| Low | $112M | $57M | $44M | $47M |
| High | $112M | $57M | $44M | $47M |
| EPS Avg | $1.16 | $0.59 | $0.46 | $0.48 |
| Low | $1.16 | $0.59 | $0.46 | $0.48 |
| High | $1.16 | $0.59 | $0.46 | $0.48 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $74M | $66M | $61M | $62M | $63M | $62M |
| Low | $74M | $66M | $61M | $62M | $63M | $62M |
| High | $74M | $66M | $61M | $62M | $63M | $62M |
| EBITDA Avg | $30M | $26M | $24M | $25M | $25M | $25M |
| Low | $30M | $26M | $24M | $25M | $25M | $25M |
| High | $30M | $26M | $24M | $25M | $25M | $25M |
| EBIT Avg | $17M | $15M | $13M | $14M | $14M | $14M |
| Low | $17M | $15M | $13M | $14M | $14M | $14M |
| High | $17M | $15M | $13M | $14M | $14M | $14M |
| Net Income Avg | $32M | $25M | $17M | $15M | $13M | $13M |
| Low | $32M | $25M | $17M | $15M | $13M | $13M |
| High | $32M | $25M | $17M | $15M | $13M | $13M |
| EPS Avg | $0.33 | $0.26 | $0.17 | $0.15 | $0.14 | $0.13 |
| Low | $0.33 | $0.26 | $0.17 | $0.15 | $0.14 | $0.13 |
| High | $0.33 | $0.26 | $0.17 | $0.15 | $0.14 | $0.13 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |